• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Medicines

Medicines

  1. FDA Advisory Committee Recommends Approval of The Medicines Company's Antiplatelet Therapy Cangrelor

    FDA Advisory Committee Recommends Approval of The Medicines Company's Antiplatelet Therapy Cangrelor

  2. Medicines Co. stock halted ahead of FDA review of heart drug

    Medicines Co. stock halted ahead of FDA review of heart drug

  3. UPDATE: A one-two punch may be lurking for oil

    UPDATE: A one-two punch may be lurking for oil

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.